In our study, we identified the RAP1-NF-κB axis as the target of miR-486-5p in regulating the cisplatin resistance of NSCLC, and miR-486-5p levels could be elevated by propofol. The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.